期刊文献+

晚期糖基化终末产物与骨质疏松 被引量:8

Advanced glycation endproducts and osteoporosis
暂未订购
导出
摘要 晚期糖基化终末产物(Advanced glycation endproducts,AGEs)是一类经由糖,包括通过Maillard反应形成的代谢中间产物化学修饰的蛋白。AGEs具有高度交联性。AGE介导的交联蛋白的一个显著特点是降低了溶解度以及减弱了抗蛋白水解的抵抗力。这一作用可引起受累组织生物物理/机械性能的改变,包括强度和刚性的增加。AGE与AGE受体(如RAGE)的相互作用诱导了受体承载细胞核因子-κB(NF-κB)的活化,同时这一作用还诱导了细胞因子、生长因子及黏附分子表达的增加。骨蛋白也会受AGE化学修饰的影响。有研究认为骨蛋白的糖基化修饰影响破骨细胞(骨吸收),成骨细胞(骨形成),以及骨基质(性质及降解)等。 Advanced glycation endproducts (AGEs) are chemical modifications of proteins by carbohydrates including those metabolic intermediates formed during the Maillard reaction. AGEs have a tendency to polymerize. A remarkable feature of AGE-mediated cross-linked proteins is decreased solubility and resistance to proteolytic digestion. This effect results in altered biomechanical properties in affected proteins including increased stiffness and rigidity. The AGE-RAGE interaction additionally induces activation of nuclear factor κB (NF-κB) in RAGE bearing cells. This interaction results in increased expression of cytokines, growth factors and adhesion molecules. Bone proteins are also affected by AGE modification. Investigations support the hypothesis that bone protein glycation influences osteoclasts (bone resorption ), osteoblasts (bone formation ), bone matrix (quality and degradation), and so on.
出处 《中国骨质疏松杂志》 CAS CSCD 2007年第4期284-287,共4页 Chinese Journal of Osteoporosis
关键词 骨质疏松 骨重建 晚期糖基化终末产物 成骨细胞 破骨细胞 Osteoporosis Bone remodelling AGEs Osteoblast Osteoclast
  • 相关文献

参考文献19

  • 1Lu C,He JC,Cai W,et al.Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells.Proc Natl Acad Sci USA,2004,101(32):11767-11772.
  • 2Dumitriu IE,Baruah P,Valentinis B,et al.Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products.J Immunol,2005,174(12):7506-7515.
  • 3Wang X,Shen X,Li X,et al.Age-related changes in the collagen network and toughness of bone.Bone,2002,31:107-114.
  • 4Corthay A,Backlund J,Holmdahl R.Role of glycopeptide-specific T cells in collagen-induced arthritis:an example how post-translational modifi-cation of proteins may be involved in autoimmune disease.Ann Med,2001,33:456-465.
  • 5Yuan Z,Feldman RJ,Sun M,et al.Inhibition of JNK by cellular stress-and tumor necrosis factor a-induced AKT2 through activation of the NFkB pathway in human epithelial cells.J Biol Chem,2002,277:29973-29982.
  • 6Gu L,Hagiwara S,Fan Q,et al.Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.Nephrol Dial Transplant,2006,21:299-313.
  • 7Charoonpatrapong K,Shah R,Robling AG,et al.HMGB1 expression and release by bone cells.J Cell Physiol,2006,207(2):480-490.
  • 8Hermani A,De Servi B,Medunjanin S,et al.S100A8 and S100A9 activate MAP kinase and NF-kappaB signalling pathways and trigger translocation of RAGE in human prostate cancer cells.Exp Cell Res,2006,312:184-197.
  • 9Kume S,Kato S,Yamagishi S,et al.Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue,cartilage,and bone.J Bone Miner Res,2000,1647-1658.
  • 10Mccarthy AD,Etcheverry SB,Bruzzone L,et al.Nonenzymatic glycosylation of a type Ⅰ collagen matrix:effects on osteoblastic development and oxidative stress.BMC Cell Biol,2001,2:16-23.

同被引文献101

引证文献8

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部